Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain)

被引：0
|
作者：
Pilar Blay
Iñigo Santamaría
Ana S Pitiot
María Luque
Marta G Alvarado
Ana Lastra
Yolanda Fernández
Ángeles Paredes
José MP Freije
Milagros Balbín
机构：
[1] Calle de Celestino Villamil,Unidad de Cáncer Familiar, Servicio de Oncología Médica, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Hospital Universitario Central de Asturias (HUCA)
[2] HUCA,Laboratorio de Oncología Molecular, IUOPA, Laboratorio de Medicina
[3] Calle de Celestino Villamil,Servicio de Oncología Médica, IUOPA, HUCA
[4] Calle de Celestino Villamil,Dpto. de Bioquímica y Biología Molecular, IUOPA
[5] Universidad de Oviedo,undefined
[6] Calle de Fernando Bongera,undefined
来源：
BMC Cancer | / 13卷
关键词：
Hereditary breast and ovarian cancer; Recurrent mutations; Asturian population;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain)
    Blay, Pilar
    Santamaria, Inigo
    Pitiot, Ana S.
    Luque, Maria
    Alvarado, Marta G.
    Lastra, Ana
    Fernandez, Yolanda
    Paredes, Angeles
    Freije, Jose M. P.
    Balbin, Milagros
    BMC CANCER, 2013, 13
  • [2] Mutational analysis of BRCA1 and BRCA2 genes in Peruvian families with hereditary breast and ovarian cancer
    Buleje, Jose
    Guevara-Fujita, Maria
    Acosta, Oscar
    Huaman, Francia D. P.
    Danos, Pierina
    Murillo, Alexis
    Pinto, Joseph A.
    Araujo, Jhajaira M.
    Aguilar, Alfredo
    Ponce, Jaime
    Vigil, Carlos
    Castaneda, Carlos
    Calderon, Gabriela
    Gomez, Henry L.
    Fujita, Ricardo
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2017, 5 (05): : 481 - 494
  • [3] Hereditary breast/ovarian cancer families: beyond BRCA1 and BRCA2
    Fragoso, S.
    Santos, S.
    Mira, B.
    Machado, P.
    Luis, A.
    Clara, A.
    Opiniao, A.
    Bento, S.
    Miguel, I.
    Rodrigues, P.
    Parreira, J.
    Simoes, C.
    Vaz, F.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 568 - 568
  • [4] BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer
    Thomassen, Mads
    Hansen, Thomas V. O.
    Borg, Ake
    Lianee, Henriette Theilmann
    Wikman, Friedrik
    Pedersen, Inge Sokilde
    Bisgaard, Marie Luise
    Nielsen, Finn C.
    Kruse, Torben A.
    Gerdes, Anne-Marie
    ACTA ONCOLOGICA, 2008, 47 (04) : 772 - 777
  • [5] Risk of ovarian cancer in BRCA1 and BRCA2 mutation negative hereditary breast cancer families
    Kauff, ND
    Mitra, N
    Robson, ME
    Hurley, KE
    Chuai, S
    Goldfrank, D
    Wadsworth, E
    Lee, J
    Cigler, T
    Borgen, PI
    Norton, L
    Barakat, RR
    Offit, K
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (18): : 1382 - 1384
  • [6] Featuring BRCA1 and BRCA2 germline mutational landscape from Asturias (North Spain)
    Pitiot, Ana S.
    Blay, Pilar
    Diaz-Navarro, Ander
    Fernandez-Arrojo, Sara
    Romero, Rosa
    Alvarez-Eguiluz, Angel
    Alvarado, Marta G.
    Alvarez, Nieves
    Garcia-Teijido, Paula
    Fernandez, Yolanda
    Palacio, Isabel
    Puente, Xose S.
    Balbin, Milagros
    CLINICAL GENETICS, 2024, 106 (04) : 525 - 531
  • [7] BRCA1 and BRCA2 in hereditary breast cancer
    Scully, R
    Puget, N
    BIOCHIMIE, 2002, 84 (01) : 95 - 102
  • [8] Indications for BRCA1 and BRCA2 mutation testing in hereditary breast and ovarian cancer families.
    Schmutzler, R
    Schwarz-Boeger, U
    Bastert, G
    Deininger, J
    Hahn, W
    Kast, K
    Prieshof, B
    Volm, T
    Kiechle, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 889S - 889S
  • [9] Prevalence of BRCA1 and BRCA2 founder mutations in Brazilian hereditary breast and ovarian cancer families
    Ewald, I. P.
    Vargas, F. R.
    Moreira, M. A.
    Filho, C. M.
    da Cunha, D. R.
    Ramos, J. P.
    Ribeiro, P. L.
    Caleffi, M.
    Giugliani, R.
    Ashton-Prolla, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families
    Cierniková, S
    Tomka, M
    Kovác, M
    Stevurková, V
    Zajac, V
    NEOPLASMA, 2006, 53 (02) : 97 - 102
12345